Brief: BrightPath Biotherapeutics says exercise of options

BrightPath Biotherapeutics Co

22/01/2018 06:37

Jan 22 (Reuters) - BrightPath Biotherapeutics Co Ltd 
 4594.T  : 
       
    * Says 4,500 units of its 12th series options were exercised 
to 
450,000 shares of its common stock, during the period from Jan. 
16 to Jan. 22 
 
     
    Source text in Japanese: https://goo.gl/JHEQvh 
    Further company coverage: 4594.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724; 
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))